Abstract:Objective To investigate the significance of nucleoporin 85 (NUP85) ex-pression in hepatocellular carcinoma (HCC) and analyze its relevance to immune response. Methods A comprehensive analysis was conducted using various online databases to assess the mRNA and protein expression of NUP85 in HCC, as well as its mutation status and prognostic diagnostic value. The immune relevance of NUP85 was evaluated using single-cell sequencing data and resources from the Tumor Immune Estimation Resource (TIMER) and the Gene Expression Profiling Interactive Analysis 2021 (GEPIA2021) databases. The drug sensitivity of NUP85 was analyzed through the Genomic Landscape of Cancer (GSCA) and the Clinical Bioinformatics Home. Co-expressed genes of NUP85 in HCC were filtered using the Hepatocellular Carcinoma Comprehensive Molecular Database (HCCDB), and the correlation between NUP85 and its related genes was analyzed using the R language "limma" package. The gene ontology (GO) functions, Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) of NUP85 and its related genes were performed using the R language "clusterProfiler" package. The Clinical Bioinformatics Home was utilized to construct heatmaps and prognostic risk scoring models for NUP85 and its related genes. Results NUP85 mRNA and protein expression were upregulated in HCC, showing high levels across dif-ferent stages and grades, which indicates a poor prognosis for patients. The mutation rate of NUP85 in HCC samples was 19%, significantly affecting the overall survival (OS), disease-specific survival (DSS), and progression-free survival (PFS) of patients. NUP85 was highly expressed in various immune cells, including macrophages, B cells, and T cells, and was positively correlated with the infiltration levels of multiple immune cells. The expression of NUP85 was significantly correlated with multiple drugs, such as Milademetan (PD0325901), a structural analog of Vemurafenib (PLX4720), and Regorafenib (PD0325901). The GO functions of NUP85 and its co-expressed genes were mainly enriched in organelle fission, nuclear division, and chromosome segregation, while the KEGG pathways were primarily enriched in the cell cycle and kinesin proteins. These factors significantly and unfavorably affected the OS of HCC patients, and the areas under the ROC curve (AUC) for the 1-year, 3-year, and 5-year OS prognostic diagnosis of HCC patients were all greater than 0.7. Conclusion The high expression of NUP85 in HCC is correlated with a poor prognosis and is related to various immune cells and drugs, making it a potential biomarker for di-agnosis, treatment, and prognosis in HCC.

Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma.

Numb Negatively Regulates the Epithelial-to-mesenchymal Transition in Colorectal Cancer Through the Wnt Signaling Pathway.

Prognostic and Biological Role of the N-Myc Downstream-Regulated Gene Family in Hepatocellular Carcinoma.

Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.

Loss of Numb promotes hepatic progenitor expansion and intrahepatic cholangiocarcinoma by enhancing Notch signaling

Expressions of Nucleoside Diphosphate Kinase (nm23) in Tumor Tissues Are Related with Metastasis and Length of Survival of Patients with Hepatocellular Carcinoma

UBE2S and UBE2C Confer a Poor Prognosis to Breast Cancer Via Downregulation of Numb

The relationship between Numb/Notch1 expression and clinical features of colorectal cancer

Numb−/low Enriches a Castration-Resistant Prostate Cancer Cell Subpopulation Associated with Enhanced Notch and Hedgehog Signaling

NKD1 Correlates with a Poor Prognosis and Inhibits Cell Proliferation by Inducing P53 Expression in Hepatocellular Carcinoma

Upregulator Of Cell Proliferation Predicts Poor Prognosis In Hepatocellular Carcinoma And Contributes To Hepatocarcinogenesis By Downregulating Foxo3a

Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma

Numb Suppression Promoted the Pathogenesis of SiHa Cells by Stimulating Notch and Hedgehog Signaling Pathways

Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration

Nucleolar protein 6 promotes cell proliferation and acts as a potential novel prognostic marker for hepatocellular carcinoma

[Analysis of correlation between high expression of nucleoporin 85 (NUP85) and immune cell infiltration in hepatocellular carcinoma]

Up-regulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma]

Alternatively Activated NUSAP1 Promotes Tumor Growth and Indicates Poor Prognosis in Hepatocellular Carcinoma.

Elevated Expression of Neuropilin-2 Associated with Unfavorable Prognosis in Hepatocellular Carcinoma

Prognostic Significance of Co-Expression of Nm23 and P57 Protein in Hepatocellular Carcinoma

Increased Expression of Hepatocyte Nuclear Factor 4 Alpha Transcribed by Promoter 2 Indicates a Poor Prognosis in Hepatocellular Carcinoma.